Compliance Rate

Compliance Rate 48.0%
Compliant submissions 48
Incompliant submissions 52
Total trials 100

Your Clinical Trials

Showing 540925 of 542236 entries
View as:

Minimally Invasive Control of Epistaxis (MICE)

Phase: N/A Priority: Normal
NCT ID: NCT00666471 Org: User:
Start: 06/30/08 End: 06/30/09 Due: 06/30/10

A Study to Compare the Safety and Efficacy of Romosozumab (AMG 785) Versus Placebo in Men With Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT02186171 Org: User:
Start: 06/16/14 End: 04/20/16 Due: 04/20/17

Clinical and Biological Efficacy of Peanut Oral Immunotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02979600 Org: User:
Start: 09/30/15 End: 12/31/15 Due: 12/31/16

Pembrolizumab With Standard Cytotoxic Chemotherapy in Treatment Naive NSCLC Patients With Asymptomatic Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT04967417 Org: User:
Start: 05/26/22 End: 12/02/24 Due: 12/02/25

Use of a Treated, Devitalized and Sterile Meniscus Segment (MENISC-T) in the Treatment of Scaphotrapeziotrapezoid Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT05250726 Org: User:
Start: 01/01/21 End: 02/08/24 Due: 02/08/25

Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00588276 Org: User:
Start: 06/30/05 End: 06/30/12 Due: 06/30/13

Magnetic Resonance Imaging (MRI) for Early Diagnosis of Cystic Fibrosis (CF)

Phase: N/A Priority: Normal
NCT ID: NCT00760071 Org: User:
Start: 07/31/06 End: 09/30/09 Due: 09/30/10

ZEPHYR: A Study Evaluating Surgical Outcome After Implantation of the Zephyr ZSI 475 FTM Inflatable Penile Implant in the Neophallus After Female-to-male Sex Reassignment Surgery

Phase: N/A Priority: Normal
NCT ID: NCT04064671 Org: User:
Start: 09/19/17 End: 12/31/29 Due: 12/31/30

Real-World Outcome of Psoriasis Subjects in Korea on Adalimumab

Phase: N/A Priority: Normal
NCT ID: NCT03099083 Org: User:
Start: 03/31/17 End: 04/05/19 Due: 04/05/20

FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02890355 Org: User:
Start: 09/01/16 End: 03/17/26 Due: 03/17/27

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

Phase: N/A Priority: Normal
NCT ID: NCT05050084 Org: User:
Start: 12/06/21 End: 11/11/26 Due: 11/11/27

The Effect of Total Intravenous Anesthesia and Volatile Anesthesia on Shedding of the Endothelial Glycocalyx in Patients Undergoing Laparoscopic or Robotic Assisted Gastrectomy

Phase: N/A Priority: Normal
NCT ID: NCT04183296 Org: User:
Start: 11/28/19 End: 08/03/20 Due: 08/03/21

Stress Reduction in the Prevention of Left Ventricular Hypertrophy

Phase: N/A Priority: Normal
NCT ID: NCT05373732 Org: User:
Start: 04/30/96 End: 12/31/98 Due: 12/31/99

Canola-Mediterranean Diet Study in T2DM

Phase: N/A Priority: Normal
NCT ID: NCT02245399 Org: User:
Start: 10/31/14 End: 03/13/17 Due: 03/13/18

Accuracy of Digital Implant Impression

Phase: N/A Priority: Normal
NCT ID: NCT04627649 Org: User:
Start: 12/31/20 End: 02/28/21 Due: 02/28/22

Expanded Access Program With Lanadelumab for Japanese People With Hereditary Angioedema

Phase: N/A Priority: Normal
NCT ID: NCT04687137 Org: User:
Start: 02/10/21 End: 06/18/22 Due: 06/18/23

Atorvastatin Calcium in Preventing Metabolic Syndrome in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01555632 Org: User:
Start: 03/31/12 End: 02/28/13 Due: 02/28/14

Impact of Rituximab on MRI Evidence of Disease Activity in Patients With Moderate to Severe Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00425932 Org: User:
Start: 02/28/07 End: 11/30/12 Due: 11/30/13

Individualized Treatment Strategy for Patients With Metastatic Non-clear Cell Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04644432 Org: User:
Start: 03/06/20 End: 09/06/22 Due: 09/06/23

Study Evaluating The Effect Of High-Fat Meal On Bioavailability And Pharmacokinetics Of Single Dose Of Moxidectin

Phase: N/A Priority: Normal
NCT ID: NCT00736697 Org: User:
Start: 11/30/08 End: 05/31/09 Due: 05/31/10

Assessment of Varying Oral Dosing Regimens for F901318 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03340597 Org: User:
Start: 12/12/17 End: 04/13/18 Due: 04/13/19

Vytorin (10/20 Or 10/40) Compared to Atorvastatin (10 mg or 20 mg) in Patients With Coronary Artery Disease (0653A-126)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00442897 Org: User:
Start: 09/30/06 End: 10/31/08 Due: 10/31/09

The Effect of a Protective Message on Critical Evaluation of Fake News

Phase: N/A Priority: Normal
NCT ID: NCT05030883 Org: User:
Start: 05/10/19 End: 07/01/19 Due: 07/01/20

Efficacy Study of Delayed Primary Closure to Reduce Rate of Wound Infection in Complicated Appendicitis

Phase: N/A Priority: Normal
NCT ID: NCT01659983 Org: User:
Start: 11/30/12 End: 03/31/16 Due: 03/31/17

PREvention of Intrauterine Adhesion After Hysteroscopic Surgery With Novel deGradable Film

Phase: N/A Priority: Normal
NCT ID: NCT04381728 Org: User:
Start: 11/18/19 End: 03/15/21 Due: 03/15/22